Although no high penetrance mutations were found, two polymorphisms were identified, one at codon 12 (PPARGP12A) and the other at codon 449 (PPARGH449H) of the PPARG gene, and these were found to be highly over-represented in patients with GBM when compared to the matched control group (12). The gene discussed is PPARG; the disease is glioblastoma.